Chondroitinase compositions
    1.
    发明授权
    Chondroitinase compositions 失效
    软骨素酶组成

    公开(公告)号:US6007810A

    公开(公告)日:1999-12-28

    申请号:US70763

    申请日:1998-05-01

    摘要: This invention provides pharmaceutical compositions containing chondroitinase wherein a decrease in enzyme activity is very little even after long-term storage, and the pharmaceutical compositions are characterized in that they contain chondroitinase and a pharmaceutical carrier, and that an amount of reducing impurities per 1 g of said pharmaceutical carrier is 0.4 mL or less as a titer by a titration method with 0.01 N of ammonium ceric nitrate.

    摘要翻译: 本发明提供含有软骨素酶的药物组合物,其中即使长期保存后酶活性的降低也很少,并且药物组合物的特征在于它们含有软骨素酶和药物载体,并且每1g 所述药物载体通过滴定法用0.01N硝酸铈铵滴定为0.4mL以下。